Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Here are some reasons for why you wouldnt to switch - The SURMOUNT-5 trial, the first head-to-head comparison of the two medications, published in the New England Journal of Medicine in May 2025, found that tirzepatide (Mounjaro 15mg) produced 20.2% average weight loss at 72 weeks, compared to 13.7% for semaglutide (Wegovy 2.4mg)
Rated 5 out of 5 Caryn M
Gulati 2015
bunion deformities
GLP-1 RAs may offer support, but they need to be used in conjunction with regular management routines
US$ 20.01
US$ 26.65
US$ 29.88
